Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Zeo ScientifiX Inc./ 10-KT

SEC Filing · 10-KT

Zeo ScientifiX Inc.

ZEOXOTCEQUITYCurrent

SEC Filing

Filed Oct 13, 2026Accepted Oct 13, 2026, 4:04 PM EDTCIK 1557376Accession 0001829126-26-011071
View company →Permanent SEC source ↗
Share

Company context

We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company’s proprietary products, including Zofin™, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X™ (“PPX™”), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient’s own peripheral blood (“RAAM Products”).

Current securities

ZEOXOTC · EQUITY · Current
Historical securities (7)
BPSRNYSE_AMERICAN · EQUITY · Historical · closed Nov 5, 2021BPSROTC · EQUITY · Historical · closed Sep 24, 2015BPSROTC · EQUITY · Historical · closed Nov 8, 2021BPSREOTC · EQUITY · Historical · closed Oct 1, 2015OCELOTC · EQUITY · Historical · closed Nov 28, 2023OCELOTC · EQUITY · Historical · closed Mar 5, 2024OCELDOTC · EQUITY · Historical · closed Dec 22, 2023

Recent company filings

  1. Other EventsNov 3, 2026
  2. Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesOct 30, 2026
  3. Entry into a Material Definitive AgreementOct 26, 2026
  4. NT 10-K filingSep 28, 2026
  5. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearSep 15, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.